Optimapharm Estonia OÜ
Optimapharm Estonia OÜ is a OÜ based in Tallinn, registry code 12856444, status: active. Main activity: Other business support service activities n.e.c.. According to EMTA, turnover for Q3 2026 was €98 895 with 4 employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 98 895 €above 84% of companiesindustry median 14 665 € · companies in the industry: 1 226
- Labour taxes per employee 8 438 €above 98% of companiesindustry median 1 350 € · companies in the industry: 776
- Revenue · 2025 397 029 €above 98% of companiesindustry median 3 483 € · companies in the industry: 3 688
- Net profit margin · 2025 13.3 %above 52% of companiesindustry median 11.2 % · companies in the industry: 2 113
Taxes and turnover
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 98 895 | 30 627 | 33 750 | 4 |
| Q2 2026 | 85 188 | 31 985 | 34 874 | 3 |
| Q1 2026 | 185 296 | 28 123 | 30 751 | 3 |
| Q4 2025 | 917 | 30 099 | 32 745 | 3 |
| Q3 2025 | 227 837 | 30 555 | 33 222 | 3 |
| Q2 2025 | 967 | 38 663 | 41 739 | 3 |
| Q1 2025 | 247 189 | 71 013 | 76 281 | 3 |
| Q4 2024 | 384 378 | 93 358 | 99 634 | 15 |
| Q3 2024 | 208 106 | 101 620 | 108 652 | 16 |
| Q2 2024 | 172 911 | 124 892 | 134 030 | 16 |
| Q1 2024 | 640 995 | 98 345 | 105 333 | 17 |
| Q4 2023 | 274 268 | 93 606 | 100 125 | 16 |
| Q3 2023 | 266 224 | 90 548 | 97 301 | 16 |
| Q2 2023 | 318 808 | 109 542 | 117 088 | 16 |
| Q1 2023 | 288 786 | 93 069 | 99 106 | 16 |
| Q4 2022 | 280 191 | 91 128 | 96 632 | 19 |
| Q3 2022 | 283 684 | 96 454 | 102 786 | 17 |
| Q2 2022 | 294 840 | 120 137 | 125 847 | 19 |
| Q1 2022 | 320 273 | 132 238 | 140 312 | 21 |
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 397 029 | 52 926 | 297 058 | 710 133 | 537 659 | 3 |
| 2024 | 1 202 108 | 82 658 | 1 018 135 | 719 593 | 484 734 | 17 |
| 2023 | 1 384 027 | 90 058 | 1 077 274 | 702 925 | 402 076 | 17 |
| 2022 | 1 181 932 | 43 742 | 977 343 | 413 439 | 312 018 | 20 |
| 2021 | 1 506 644 | 57 948 | 1 228 496 | 424 058 | 268 276 | 25 |
| 2020 | 1 127 007 | 43 327 | 898 493 | 377 610 | 210 328 | 20 |
| 2019 | 1 138 476 | 36 679 | 861 603 | 354 955 | 167 001 | 23 |
| 2018 | — | — | — | — | — | 23 |
| 2017 | — | — | — | — | — | 22 |
| 2016 | — | — | — | — | — | 22 |
| 2015 | — | — | — | — | — | 22 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 30 Jun 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 14 Jul 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 2 Jul 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 1 Sep 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 28 Feb 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 16 Mar 2021 | Company’s own | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 30 Apr 2020 | Company’s own | e-Äriregister |
Board
- Ivana WallerBoard member · since 2 Mar 2023
- Miguel Angel Salcedo IglesiasBoard member · since 2 Mar 2023
- Grant Thornton Baltic OÜContact person · since 3 Mar 2026
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Optimapharm Nordic OyLegal person · 2 500 €
Beneficial owners
- Nicolas S RohatynIndirect ownership · USA · since 27 Sep 2022
Founders and other persons
No other persons.
Activities (EMTAK)
- 82991Other business support service activities n.e.c. Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50007573 / 17 3 Mar 2026 |
Amendment entry | In force 3 Mar 2026 |
||
| Ä 50007573 / 16 2 Feb 2026 |
Amendment entry | In force 2 Feb 2026 |
||
| Ä 50007573 / 15 5 Dec 2024 |
Amendment entry | In force 5 Dec 2024 |
||
| Ä 50007573 / 14 26 Sep 2024 |
Amendment entry | In force 26 Sep 2024 |
||
| Ä 50007573 / 13 23 Sep 2024 |
Amendment entry | In force 23 Sep 2024 |
||
| Ä 50007573 / 12 21 Sep 2024 |
Amendment entry | In force 21 Sep 2024 |
||
| Ä 50007573 / 11 21 Sep 2024 |
Amendment entry | In force 21 Sep 2024 |
||
| Ä 50007573 / M5 16 Jan 2024 |
Procedural ruling | 26 Jan 2024 | Deficiencies eliminated 23 Jan 2024 |
|
| Ä 50007573 / 10 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 50007573 / 9 2 Mar 2023 |
Amendment entry | In force 2 Mar 2023 |
||
| Ä 50007573 / 8 26 Sep 2022 |
Amendment entry | In force 26 Sep 2022 |
||
| Ä 50007573 / 7 14 Jun 2022 |
Amendment entry | In force 14 Jun 2022 |
||
| Ä 50007573 / M4 2 Jun 2022 |
Procedural ruling | In force 2 Jun 2022 |
||
| Ä 50007573 / 6 14 Jul 2021 |
Amendment entry | In force 14 Jul 2021 |
||
| Ä 50007573 / 5 17 Jul 2019 |
Amendment entry | In force 17 Jul 2019 |
||
| Ä 50007573 / M3 16 Jul 2019 |
Procedural ruling | 26 Jul 2019 | Deficiencies eliminated 17 Jul 2019 |
|
| Ä 50007573 / 4 8 Nov 2018 |
Amendment entry | In force 8 Nov 2018 |
||
| Ä 50007573 / 3 18 Jan 2018 |
Amendment entry | In force 18 Jan 2018 |
||
| Ä 50007573 / 2 12 Oct 2015 |
Amendment entry | In force 12 Oct 2015 |
||
| Ä 50007573 27 May 2015 |
First entry | In force 27 May 2015 |
||
| Ä 50007573 / M2 11 May 2015 |
Ruling to eliminate deficiencies | 10 Jun 2015 | Deficiencies eliminated 27 May 2015 |
|
| Ä 50007573 / M1 4 May 2015 |
Ruling to eliminate deficiencies | 3 Jun 2015 | Deficiencies eliminated 27 May 2015 |
Sources: e-Äriregister and EMTA. Data updated 27 Oct 2026. Open at the source ↗ · Report an error in the data